Jody Lynn Baron, MD, PhD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jody Lynn Baron, MD, PhD

Assistant Professor of Medicine, Department of Medicine (Infectious Diseases and Gastroenterology), UCSF

jody.baron@ucsf.edu

Phone: (415) 476-5728 (appts)
Box 0538, UCSF
San Francisco, CA 94143-0532

View on UCSF Profiles

Cancer Center Membership

Program Member » Cancer, Immunity, and Microenvironment

Education

Swarthmore College, Swarthmore, PA, 1984-85 Rice University, Houston, Texas, BA, 1986, Biology & Philosophy
Yale University, MD 1993, Medicine
Yale University, PhD, 1994, Immunobiology
Stanford University, Residency, 1993-95 Internal Medicine
University of California, San Francisco, Clinical Fellow, 1995-96, Infectious Diseases
University of California, San Francisco, Fellowship, 1996-2000, Microbiol & Immunology
 


Professional Experience

  • 2000- 2002
    Assistant Research Scientist Departments of Microbiology and Immunology, and Internal Medicine, University of California, San Francisco
  • 2003-2
    Assistant Professor of Medicine Department of Medicine, Divisions of Infectious Diseases & Gastroenterology (UCSF Liver Center), University of California, San Francisco

Honors & Awards

  • 1982
    Westinghouse Science Talent Search honors group
  • 1992
    NIH Resident research award
  • 1986-1992
    NIH Fellowship -Medical Scientist Training Program Yale University
  • 1992
    Molecular Medicine Fellowship, University of California at San Francisco
  • 1997-2002
    Howard Hughes Postdoctoral Research Fellowship for Physicians
  • 1992
    UCSF Liver center pilot research grant
  • 2000-2002
    Pfizer Postdoctoral Fellowship in Infectious Diseases
  • 2003-2002
    Burroughs Wellcome Career Award in the Biomedical Sciences
  • 2002
    HHMI/BWF Leadership Coaching Award
  • 2002
    American Gastroenterological Association Fiterman Basic Science Award
  • 2004-2002
    American Liver Foundation Liver Scholar Award
  • 2005-2002
    Cancer Research Institute Investigator award
  • 2006-2011
    Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease
  • 2011-2013
    UCSF Program in Breakthrough Biomedical Research Award

Selected Publications

  1. Liver capsule: Age-influenced hepatic immune priming determines HBV infection fate: Implications from mouse to man. Hepatology. 2016 Jan; 63(1):260.
    View on PubMed
  2. TGF-ß-Dependent Dendritic Cell Chemokinesis in Murine Models of Airway Disease. J Immunol. 2015 Aug 1; 195(3):1182-90.
    View on PubMed
  3. A Critical Role for Dendritic Cells in the Evolution of IL-1ß-Mediated Murine Airway Disease. J Immunol. 2015 Apr 15; 194(8):3962-9.
    View on PubMed
  4. Selective targeting of TGF-ß activation to treat fibroinflammatory airway disease. Sci Transl Med. 2014 Jun 18; 6(241):241ra79.
    View on PubMed
  5. Production of factor VIII by human liver sinusoidal endothelial cells transplanted in immunodeficient uPA mice. PLoS One. 2013; 8(10):e77255.
    View on PubMed
  6. Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B. J Clin Invest. 2013 Sep 3; 123(9):3728-39.
    View on PubMed
  7. Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity. Nat Med. 2012 Jul; 18(7):1060-8.
    View on PubMed
  8. Mouse and human lung fibroblasts regulate dendritic cell trafficking, airway inflammation, and fibrosis through integrin avß8-mediated activation of TGF-ß. J Clin Invest. 2011 Jul; 121(7):2863-75.
    View on PubMed
  9. IL-21 is pivotal in determining age-dependent effectiveness of immune responses in a mouse model of human hepatitis B. J Clin Invest. 2011 Mar; 121(3):1154-62.
    View on PubMed
  10. Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus. Proc Natl Acad Sci U S A. 2007 Nov 13; 104(46):18187-92.
    View on PubMed
  11. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J Exp Med. 2003 Oct 6; 198(7):1069-76.
    View on PubMed
  12. Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo. Proc Natl Acad Sci U S A. 2003 Jul 8; 100(14):8395-400.
    View on PubMed
  13. The integrin alpha(v)beta8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-beta1. J Cell Biol. 2002 Apr 29; 157(3):493-507.
    View on PubMed
  14. Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity. 2002 Apr; 16(4):583-94.
    View on PubMed
  15. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc Natl Acad Sci U S A. 2001 Sep 25; 98(20):11521-6.
    View on PubMed

Go to UCSF Profiles, powered by CTSI